<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000641164"><TermName>TRAIL</TermName><TermPronunciation>(trayl)</TermPronunciation><TermDefinition><DefinitionText>A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. TRAIL is being studied in the treatment of cancer. Also called Apo-2L, TNF-related apoptosis-inducing ligand,  and tumor necrosis factor-related apoptosis-inducing ligand.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000733181" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;TRAIL&quot;" language="en" id="_3"/><MediaLink ref="CDR0000733180" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;TRAIL&quot;" language="es" id="_4"/><SpanishTermName>TRAIL</SpanishTermName><SpanishTermDefinition><DefinitionText>Proteína celular que se puede unir a ciertas moléculas de algunas células cancerosas y puede destruir las células. TRAIL está en estudio para el tratamiento de cáncer. También se llama Apo-2L, ligando inductor de apoptosis relacionada con el factor de necrosis tumoral,  y ligando inductor de apoptosis relacionada con el FNT.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-05-08</DateFirstPublished></GlossaryTerm>
